Skip to main content
SpringerLink
Log in

Preoperative Cardiac Risk Assessment and Management of Elderly Men with an Abdominal Aortic Aneurysm

  • Chapter
  • First Online:
Vascular Surgery

  • 1361 Accesses

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 109.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 139.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 219.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Mangano DT. Perioperative cardiac morbidity. Anesthesiology. 1990;72(1):153–84.

    Article  CAS  PubMed  Google Scholar 

  2. Hertzer NR, Beven EG, Young JR, et al. Coronary artery disease in peripheral vascular patients. A classification of 1000 coronary angiograms and results of surgical management. Ann Surg. 1984;199(2):223–33.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  3. Thygesen K, Alpert JS, Jaffe AS, et al. Writing group on the joint ESC/ACCF/AHA/WHF task force for the universal definition of myocardial infarction. Eur Heart J. 2012;33:2551–67.

    Article  PubMed  Google Scholar 

  4. Galal W, Hoeks SE, Flu WJ, et al. Relation between preoperative and intraoperative new wall motion abnormalities in vascular surgery patients: a transesophageal echocardiographic study. Anesthesiology. 2010;112:557–66.

    Article  PubMed  Google Scholar 

  5. Dawood MM, Gutpa DK, Southern J, Walia A, Atkinson JB, Eagle KA. Pathology of fatal perioperative myocardial infarction: implications regarding pathophysiology and prevention. Int J Cardiol. 1996;57(1):37–44.

    Article  CAS  PubMed  Google Scholar 

  6. Devereaux PJ, Xavier D, Pogue J, et al. Characteristics and short-term prognosis of perioperative myocardial infarction in patients undergoing noncardiac surgery: a cohort study. Ann Intern Med. 2011;154(8):523–8.

    Article  CAS  PubMed  Google Scholar 

  7. Botto F, Alonso-Coello P, Chan MTV, et al. Myocardial injury after noncardiac surgery: a large, international, prospective cohort study establishing diagnostic criteria, characteristics, predictors, and 30-day outcomes. Anesthesiology. 2014;120(3):564–78.

    Article  PubMed  Google Scholar 

  8. Eagle KA, Berger PB, Calkins H, et al. ACC/AHA guideline update for perioperative cardiovascular evaluation for noncardiac surgery––executive summary: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee to Update the 1996 Guidelines on Perioperative Cardiovascular Evaluation for Noncardiac Surgery). Circulation. 2002;105(10):1257–67.

    PubMed  Google Scholar 

  9. Mangano DT, Layug EL, Wallace A, Tateo I. Effect of atenolol on mortality and cardiovascular morbidity after noncardiac surgery. Multicenter Study of Perioperative Ischemia Research Group. N Engl J Med. 1996;335(23):1713–20.

    Article  CAS  PubMed  Google Scholar 

  10. Poldermans D, Boersma E, Bax JJ, et al. The effect of bisoprolol on perioperative mortality and myocardial infarction in high-risk patients undergoing vascular surgery. Dutch Echocardiographic Cardiac Risk Evaluation Applying Stress Echocardiography Study Group. N Engl J Med. 1999;341(24):1789–94.

    Article  CAS  PubMed  Google Scholar 

  11. Devereaux PJ, Yang H, Yusuf S, et al. Effects of extended-release metoprolol succinate in patients undergoing non-cardiac surgery (POISE trial): a randomised controlled trial. Lancet. 2008;371(9627):1839–47.

    Article  CAS  PubMed  Google Scholar 

  12. Wijeysundera DN, Duncan D, Nkonde-Price C, et al. Perioperative beta blockade in noncardiac surgery: a systematic review for the 2014 ACC/AHA guideline on perioperative cardiovascular evaluation and management of patients undergoing noncardiac surgery. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. Circulation. 2014;130:2246–64.

    Article  CAS  PubMed  Google Scholar 

  13. Kristensen SD, et al. The 2014 ESC/ESA guidelines on non-cardiac surgery: cardiovascular assessment andmanagement. The joint task force on non-cardiac surgery: cardiovascular assessment and management of the European Society of Cardiology (ESC) and the European Society of Anaesthesiology (ESA). Eur Heart J. 2014;35:2383–243.

    Article  PubMed  Google Scholar 

  14. Huhle G, Abletshauser C, Mayer N, Weidinger G, Harenberg J, Heene DL. Reduction of platelet activity markers in type II hypercholesterolemic patients by a HMG-CoA-reductase inhibitor. Thromb Res. 1999;95(5):229–34.

    Article  CAS  PubMed  Google Scholar 

  15. Hernandez-Perera O, Perez-Sala D, Navarro-Antolin J, et al. Effects of the 3-hydroxy-3-methylglutaryl- CoA reductase inhibitors, atorvastatin and simvastatin, on the expression of endothelin-1 and endothelial nitric oxide synthase in vascular endothelial cells. J Clin Invest. 1998;101(12):2711–9.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  16. Antoniou GA, Hajibandeh S, Hajibandeh S, et al. Meta-analysis of the effects of statins on perioperative outcomes in vascular and endovascular surgery. J Vasc Surg. 2015;61:519–32.

    Article  PubMed  Google Scholar 

  17. Schouten O, Boersma E, Hoeks SE, et al. Dutch echocardiographic cardiac risk evaluation applying stress echocardiography study group. Fluvastatin and perioperative events in patients undergoing vascular surgery. N Engl J Med. 2009;361:980–9.

    Article  CAS  PubMed  Google Scholar 

  18. Nissen SE, Stroes E, Dent-Acosta RE, on behalf of the GAUSS-3 Investigators, et al. Efficacy and tolerability of evolocumab vs ezetimibe in patients with muscle-related statin intolerance: the GAUSS-3 Randomized Clinical Trial. JAMA. 2016;315:1580–90.

    Article  CAS  PubMed  Google Scholar 

  19. Burger W, Chemnitius JM, Kneissl GD, Rucker G. Low-dose aspirin for secondary cardiovascular prevention—cardiovascular risks after its perioperative withdrawal versus bleeding risks with its continuation—review and meta-analysis. J Intern Med. 2005;257:399–414.

    Article  CAS  PubMed  Google Scholar 

  20. Devereaux PJ, Mrkobrada M, Sessler DI, et al. Aspirin in patients undergoing noncardiac surgery. N Engl J Med. 2014;370:1494–503.

    Article  CAS  PubMed  Google Scholar 

  21. Douketis JD, Spyropoulos AC, Kaatz S, et al. Perioperative bridging anticoagulation in patients with atrial fibrillation. BRIDGE investigators. N Engl J Med. 2015;373:823–33.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  22. Siegal D, Yudin J, Kaatz S, et al. Periprocedural heparin bridging in patients receiving vitamin K antagonists; Systematic review and meta-analysis of bleeding and tromboembolic rates. Circulation 2012;126:1630–1639.

    Google Scholar 

  23. Pollack CV Jr, Reilly PA, Eikelboom J, et al. Idarucizumab for dabigatran reversal. N Engl J Med. 2015;373:511–20.

    Article  CAS  PubMed  Google Scholar 

  24. Huisman MV, Fanikos J. Idarucizumab and factor Xa reversal agents: role in hospital guidelines and protocols. Am J Med. 2016;129:S89–96.

    Article  CAS  PubMed  Google Scholar 

  25. Hwang JW, Kim EK, Yang JH, et al. Assessment of perioperative cardiac risk of patients undergoing noncardiac surgery using coronary computed tomographic angiography. Circ Cardiovasc Imaging. 2015;8:1–10.

    Article  Google Scholar 

  26. McFalls EO, Ward HB, Moritz TE, et al. Coronary-artery revascularization before elective major vascular surgery. N Engl J Med. 2004;351:2795–804.

    Article  CAS  PubMed  Google Scholar 

  27. EY W, Lawrence HP, Wong DT. The effects of prophylactic coronary revascularization or medical management on patient outcomes after noncardiac surgery––a meta-analysis. Can J Anaesth. 2007;54:705–17.

    Article  Google Scholar 

  28. Kaluza GL, Joseph J, Lee JR, Raizner ME, Raizner AE. Catastrophic outcomes of noncardiac surgery soon after coronary stenting. J Am Coll Cardiol. 2000;35:1288–94.

    Article  CAS  PubMed  Google Scholar 

  29. Savonitto S, D’Urbano M, Caracciolo M, Barlocco F, Mariani G, Nichelatti M, et al. Urgent surgery in patients with a recently implanted coronary drug-eluting stent: a phase II study of ‘bridging’ antiplatelet therapy with tirofiban during temporary withdrawal of clopidogrel. Br J Anaesth. 2010;104:285–91.

    Article  CAS  PubMed  Google Scholar 

  30. Alshawabkeh LI, Prasad A, Lenkovsky F, Makary LF, Kandil ES, Weideman RA, et al. Outcomes of a preoperative “bridging” strategy with glycoprotein IIb/IIIa inhibitors to prevent perioperative stent thrombosis in patients with drug-eluting stents who undergo surgery necessitating interruption of thienopyridine administration. EuroIntervention. 2013;9:204–11.

    Article  PubMed  Google Scholar 

  31. Eagle KA, Rihal CS, Mickel MC, Holmes DR, Foster ED, Gersh BJ. Cardiac risk of noncardiac surgery: influence of coronary disease and type of surgery in 3368 operations. CASS Investigators and University of Michigan Heart Care Program. Coronary Artery Surgery Study. Circulation. 1997;96:1882–7.

    Article  CAS  PubMed  Google Scholar 

  32. Fleisher LA, Eagle KA, Shaffer T, Anderson GF. Perioperative- and long-term mortality rates after major vascular surgery: the relationship to preoperative testing in the Medicare population. Anesth Analg. 1999;89:849–55.

    CAS  PubMed  Google Scholar 

  33. Hassan SA, Hlatky MA, Boothroyd DB, et al. Outcomes of noncardiac surgery after coronary bypass surgery or coronary angioplasty in the Bypass Angioplasty Revascularization Investigation (BARI). Am J Med. 2001;110:260–6.

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Medicine, Spijkenisse MC, Spijkenisse, The Netherlands

    Don Poldermans M.D., Ph.D., F.E.S.C.

Authors
  1. Don Poldermans M.D., Ph.D., F.E.S.C.
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Don Poldermans M.D., Ph.D., F.E.S.C. .

Editor information

Editors and Affiliations

  1. Vascular Surgery, Division of Surgery and Cancer, Imperial College, London, United Kingdom

    George Geroulakos

  2. Department of Vascular Surgery, Yale University School of Medicine, New Haven, Connecticut, USA

    Bauer Sumpio

Rights and permissions

Reprints and permissions

Copyright information

© 2018 Springer International Publishing AG, part of Springer Nature

About this chapter

Cite this chapter

Poldermans, D. (2018). Preoperative Cardiac Risk Assessment and Management of Elderly Men with an Abdominal Aortic Aneurysm. In: Geroulakos, G., Sumpio, B. (eds) Vascular Surgery. Springer, Cham. https://doi.org/10.1007/978-3-319-65936-7_1

Download citation

  • DOI: https://doi.org/10.1007/978-3-319-65936-7_1

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-319-65935-0

  • Online ISBN: 978-3-319-65936-7

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation